These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12477434)

  • 1. Towards immunotherapy for chronic hepatitis B virus infections.
    Michel ML
    Vaccine; 2002 Dec; 20 Suppl 4():A83-8. PubMed ID: 12477434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic vaccination against chronic hepatitis B virus infection].
    Mancini-Bourgine M; Michel ML
    Therapie; 2005; 60(3):257-65. PubMed ID: 16128268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic vaccination against chronic hepatitis B virus infection.
    Michel ML; Mancini-Bourgine M
    J Clin Virol; 2005 Dec; 34 Suppl 1():S108-14. PubMed ID: 16461209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantity and quality of virus-specific CD8 cell response: relevance to the design of a therapeutic vaccine for chronic HBV infection.
    Webster G; Bertoletti A
    Mol Immunol; 2001 Dec; 38(6):467-73. PubMed ID: 11741696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic vaccination in chronic hepatitis B virus carriers.
    Pol S; Michel ML
    Expert Rev Vaccines; 2006 Oct; 5(5):707-16. PubMed ID: 17181443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide vaccines against hepatitis B virus: from animal model to human studies.
    Engler OB; Dai WJ; Sette A; Hunziker IP; Reichen J; Pichler WJ; Cerny A
    Mol Immunol; 2001 Dec; 38(6):457-65. PubMed ID: 11741695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell therapy for chronic viral hepatitis.
    Bertoletti A; Tan AT; Koh S
    Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    Reynolds TD; Buonocore L; Rose NF; Rose JK; Robek MD
    J Virol; 2015 Oct; 89(20):10407-15. PubMed ID: 26246574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Bréchot C; Michel ML
    Hepatology; 2004 Oct; 40(4):874-82. PubMed ID: 15382173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future.
    Michel ML; Pol S; Brechot C; Tiollais P
    Vaccine; 2001 Mar; 19(17-19):2395-9. PubMed ID: 11257367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of chronic hepatitis B by anti HBV vaccine.
    Pol S; Couillin I; Michel ML; Driss F; Nalpas B; Carnot F; Berthelot P; Bréchot C
    Acta Gastroenterol Belg; 1998; 61(2):228-33. PubMed ID: 9658616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Checkpoint Inhibitors and Therapeutic Vaccines for the Treatment of Chronic HBV Infection.
    Hoogeveen RC; Boonstra A
    Front Immunol; 2020; 11():401. PubMed ID: 32194573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects and progress of DNA vaccines for treating hepatitis B.
    Chen M; Jagya N; Bansal R; Frelin L; Sällberg M
    Expert Rev Vaccines; 2016 May; 15(5):629-40. PubMed ID: 26652035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory therapy for chronic hepatitis B virus infection.
    Sprengers D; Janssen HL
    Fundam Clin Pharmacol; 2005 Feb; 19(1):17-26. PubMed ID: 15660957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck.
    Kosinska AD; Liu J; Lu M; Roggendorf M
    Med Microbiol Immunol; 2015 Feb; 204(1):103-14. PubMed ID: 25535101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of core-derived epitopes from a novel HBV-targeted immunotherapeutic by T-cells from patients infected by different viral genotypes.
    Godon O; Evlachev A; Bourgine M; Meritet JF; Martin P; Inchauspe G; Michel ML
    Vaccine; 2015 Aug; 33(36):4548-53. PubMed ID: 26209840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune balance in Hepatitis B Infection: Present and Future Therapies.
    Vyas AK; Jindal A; Hissar S; Ramakrishna G; Trehanpati N
    Scand J Immunol; 2017 Jul; 86(1):4-14. PubMed ID: 28387980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
    Mancini-Bourgine M; Fontaine H; Bréchot C; Pol S; Michel ML
    Vaccine; 2006 May; 24(21):4482-9. PubMed ID: 16310901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.